Sara Ravaioli

13PUBLICATIONS
37CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Feminist methodologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 27, 2024
HDAC6 as a Prognostic Factor and Druggable Target in HER2-Positive Breast Cancer.

Michela Cortesi, Sara Bravaccini, Sara Ravaioli

|May 16, 2024
A Functional Survey of the Regulatory Landscape of Estrogen Receptor-Positive Breast Cancer Evolution.

Iros Barozzi, Neil Slaven, Eleonora Canale

|Aug 13, 2022
TROP2 (trophoblast cell-surface antigen 2): a drug target for breast cancer.

Michela Cortesi, Michele Zanoni, Roberta Maltoni

|Jan 11, 2022
Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight.

Michela Cortesi, Michele Zanoni, Francesca Pirini

|Apr 03, 2021
Expanding Roles of De Novo Lipogenesis in Breast Cancer.

Pasquale Simeone, Stefano Tacconi, Serena Longo

|Sep 12, 2020
Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be gold.

Roberta Maltoni, Michela Palleschi, Sara Ravaioli

Pageof 3